VTT, a simulated organ for surgical training by Kotobuki Giken

VTT, a simulated organ for surgical training by Kotobuki Giken

Kotobuki Giken has launched a new company to develop and sell simulated organs for surgical training using konjac. The company raised about 90 million yen through stock investment-type crowdfunding. The company will sell the products to medical equipment manufacturers as well as universities and hospitals. The company also has its sights set on overseas markets. The new company, KOTOBUKI Medical, was established with experts in venture management and medical equipment sales, and is headed by President Takayama. The company will be based in Kotobuki Giken. The new company will handle everything from the purchase of raw materials to processing and sales. The new company aims to achieve sales of 10 million yen in the fiscal year ending September 30, 2019, and to build a plant in 2008. President Takayama is enthusiastic, saying, "We want to make this a 3 billion yen business by 2016. (Photo taken on June 13, 2019, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)

  • Product Code
  • ILEA000687754
  • Registered date
  • 2019/6/13 00:00:00
  • Credit
  • THE NIKKAN KOGYO SHIMBUN / Kyodo News Images
  • Media source
  • THE NIKKAN KOGYO SHIMBUN
  • Media size
  • 4272 × 2848 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 5.59(MB)*
  • Special instruction
  • **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Shionogi's new mid-term management plan briefing

    Shionogi's new mid-term management plan briefing

    On the 1st, Shionogi announced a new mid-term management plan to invest 500 billion yen in expanding overseas business and launching new businesses by FY2024. The company will also increase research and development expenses by 20% over the past five years to about 342.1 billion yen. In addition to strengthening its own sales of pharmaceuticals in Japan and overseas, the company will also invest heavily in products and services other than ethical drugs, such as vaccines.In terms of sales strategy, the company plans to strengthen its sales in the U.S. and China, and increase the ratio of overseas sales to more than 50% in FY2012 (18.5% in FY2007). President Tedairogi said, "We aim to become a drug discovery company that people from outside the company want to work with," and also indicated that the company will place importance on alliance strategies. (Photo taken on June 1, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
      KM Biologics begins development of vaccine for novel coronavirus

      KM Biologics begins development of vaccine for novel coronavirus

      KM Biologics (Kita Ward, Kumamoto City) has started to develop a vaccine for a new coronavirus infection. At a press conference held on April 25, President Nagasato said, "Our strength lies in the fact that we have skilled technicians and facilities from our days at the Research Institute for Chemotherapy and Serotherapy (KAKETSUKEN). As a member of the Meiji Group, we will do our utmost to expand this business. The new drug will be developed jointly with the National Institute of Infectious Diseases, the Institute of Medical Science of the University of Tokyo, and the National Institute of Biomedical Innovation, Health and Nutrition. The company will consider using its Kikuchi Research Center in Kikuchi City, Kumamoto Prefecture, and its Koshi Plant in Koshi City, Kumamoto Prefecture, which are capable of producing vaccines for 57 million new influenza cases. (Photo taken on May 25, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
        In-train spraying of antiviral materials by JR West

        In-train spraying of antiviral materials by JR West

        West Japan Railway Co. (JR West) has begun anti-viral and anti-bacterial treatment of the entire interior of its trains, with plans to implement the treatment on about 3,600 cars running in the Keihanshin area by the end of September and eventually on all 5,200 cars on conventional lines. The plan is to ensure the safety and security of passengers under with corona. The system uses chemicals that have been confirmed by a third-party organization to be effective against influenza and noroviruses. The effect will last for several years, the company said. The chemicals will be sprayed on windows, seats and other places where passengers may touch them. The number of commuters and other passengers in the Kansai region is gradually returning following the lifting of the state of emergency declared for the new coronavirus infection on March 21. Kazuaki Hasegawa, president of the company, said, Photo taken on May 22, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images
          Copper fiber sheet commercialized by Good Eye

          Copper fiber sheet commercialized by Good Eye

          Good Eye (Kiryu City, Gunma Prefecture) will release GUD Sheet, a copper fiber sheet with antibacterial and antiviral effects, in June. The company commercialized four types of masks, including one priced at 4,980 yen (excluding consumption tax). The GUD sheet is a polymer fiber covered with copper foil and coated with a visible light responsive photocatalyst. In an experiment on bacteriophage, a virus that infects bacteria, it was confirmed that rubbing a finger covered with the virus on the sheet for 30 seconds reduced the number of the virus to less than 1/1000.Professor Hideyuki Itabashi of the Graduate School of Science and Engineering, Gunma University, who also serves as the company's chairman, said, "We hope to start experiments in July. The photo shows copper fiber sheets commercialized as masks and chiefs. (Photo taken on May 19, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
            Technology to etch Kai semiconductor with fluoroplastic instead of CFC gas

            Technology to etch Kai semiconductor with fluoroplastic instead of CFC gas

            The established technology will be used for dry etching, thin film formation and cleaning of silicon. Easy-to-handle gases such as argon and nitrogen are irradiated onto solid fluoropolymers to generate fluorine-containing gas. The gas is then used for plasma treatment. Using a proto device with electrodes developed for special equipment, the company irradiated nitrogen gas and etched a glass substrate, and was able to etch 40 nanometers in one minute. The company plans to achieve an etching speed of 200 nanometers for commercialization. Plasma is an unstable state in which electrons have been removed from molecules, and it modifies the surface of materials, improving adhesion and cleaning effects. (Photo taken on March 30, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
              Tohoku University and TEPCO to conduct joint research on decommissioning

              Tohoku University and TEPCO to conduct joint research on decommissioning

              The term is five years. The division will conductresearch in a wide range of fields to solve various technical problems at the decommissioning site, including evaluation technology to detect the aging deterioration of structures. With the aim of fostering human resources, a CFReND branch office will be established at the Fukushima Daiichi Nuclear Power Plant site this summer. On-site exchanges of opinions between engineers at the decommissioning site and Tohoku University faculty and graduate students will be promoted. Nobuyoshi Hara, vice president of Tohoku University (photo at right), says, "We will continue our efforts to promote decommissioning. (Photo taken on March 24, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                Foxter's Hybrid Image Processing System for AI Visual Inspection

                Foxter's Hybrid Image Processing System for AI Visual Inspection

                Foxter Corporation (Toyonaka City, Osaka Prefecture) will release in May a hybrid image processing system that combines Preferred Networks' (PFN, Chiyoda Ward, Tokyo) artificial intelligence (AI) visual inspection and conventional image processing methods.The company will market the system in Japan and China in cooperation with a subsidiary of the OPTEX Group, which is engaged in the manufacture of lighting for image processing, in terms of sales and service. The sales target is 200 units a year. Auto parts manufacturers and others have already begun to introduce the system on a trial basis. The device in the center of the photo is the AI Stellar Controller. (Photo taken on March 16, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                  Musashi Seimitsu Kogyo's AI Visual Inspection System

                  Musashi Seimitsu Kogyo's AI Visual Inspection System

                  Currently, the company is introducing the inspection machine in the mass production line of its own plant, and when it sells the machine externally, it intends to make the price of the machine equivalent to the labor cost for inspection. In the future, Musashi Seimitsu will further improve the versatility of the AI algorithm so that multiple types of parts can be inspected with a single device. Musashi Seimitsu's mainstay products are gears, ball joints and other automotive drive components. In recent years, the company has been focusing on new businesses and is accelerating its efforts in the AI field, including the establishment of a joint venture with an Israeli AI venture in 2019. In the future, the company aims to achieve sales of 100 billion yen through new businesses. Photo taken on February 21, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images
                    Yumemi Shigemi (left), president of Yumemi, and Kubo, chairman and president of EDION

                    Yumemi Shigemi (left), president of Yumemi, and Kubo, chairman and president of EDION

                    On April 23, EDION announced that it had acquired all shares of Yumemi (Yodogawa Ward, Osaka City), which operates a children's programming school called "Robodan," making it a subsidiary. The company said the shares were acquired from Akinori Shigemi, president of Yumemiru, and venture capitalists. In December 2018, EDION entered the robot programming education business for elementary and junior high school students, accelerating the expansion of the business in anticipation of making programming education compulsory in elementary schools from fiscal 2008. The amount of the stock acquisition is estimated to be around 1 billion yen. Photo taken on December 23, 2019, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images
                      Nihon Vital's "Kaisei".

                      Nihon Vital's "Kaisei".

                      Taking a hint from the fact that insects find flowers by the wavelength and light intensity of sunlight, the company has developed an "insect eye sensor" that tracks sunlight. It efficiently collects sunlight. The six optical fibers can be extended up to one kilometer and can illuminate 500 square meters. It is about 2 meters long, 2 meters wide and 2.5 meters high. The price starts at 5 million yen (excluding consumption tax). It has been used in buildings and train stations in Kumamoto Prefecture, and its sales have been about 100 million yen. It can also be used to cut infrared rays and ultraviolet rays. The company is currently producing them overseas, but will switch to domestic production within this year. The price will start at 250,000 yen (same as above). "The market for solar concentrators is worth about 20 billion yen. President Yokozawa hopes to capture a 20% share of this market. (Photo taken on December 19, 2019, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)